$617 Million is the total value of Ghost Tree Capital, LLC's 88 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IBB | New | ISHARES TRput | $28,946,000 | – | 100,000 | +100.0% | 4.69% | – |
| BIIB | New | BIOGEN INCcall | $20,347,000 | – | 65,000 | +100.0% | 3.30% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $16,253,000 | – | 125,000 | +100.0% | 2.64% | – |
| GWPH | New | GW PHARMACEUTICALS PLCcall | $13,273,000 | – | 100,000 | +100.0% | 2.15% | – |
| ABT | New | ABBOTT LABS | $12,687,000 | – | 300,000 | +100.0% | 2.06% | – |
| AERI | New | AERIE PHARMACEUTICALS INCcall | $11,322,000 | – | 300,000 | +100.0% | 1.84% | – |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $10,784,000 | – | 200,000 | +100.0% | 1.75% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $10,058,000 | – | 150,000 | +100.0% | 1.63% | – |
| MRK | New | MERCK & CO INCcall | $9,362,000 | – | 150,000 | +100.0% | 1.52% | – |
| OPHT | New | OPHTHOTECH CORPcall | $9,226,000 | – | 200,000 | +100.0% | 1.50% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $9,083,000 | – | 250,000 | +100.0% | 1.47% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $8,059,000 | – | 175,000 | +100.0% | 1.31% | – |
| CELG | New | CELGENE CORPcall | $7,840,000 | – | 75,000 | +100.0% | 1.27% | – |
| CYNO | New | CYNOSURE INCcl a | $7,641,000 | – | 150,000 | +100.0% | 1.24% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $6,720,000 | – | 750,000 | +100.0% | 1.09% | – |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $6,653,000 | – | 250,000 | +100.0% | 1.08% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $6,362,000 | – | 200,000 | +100.0% | 1.03% | – |
| RTRX | New | RETROPHIN INC | $5,595,000 | – | 250,000 | +100.0% | 0.91% | – |
| IONS | New | IONIS PHARMACEUTICALS INCcall | $5,496,000 | – | 150,000 | +100.0% | 0.89% | – |
| QGEN | New | QIAGEN NV | $5,488,000 | – | 200,000 | +100.0% | 0.89% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $4,718,000 | – | 125,000 | +100.0% | 0.76% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $4,482,000 | – | 175,000 | +100.0% | 0.73% | – |
| PTHN | New | PATHEON N V | $4,298,000 | – | 275,700 | +100.0% | 0.70% | – |
| ZGNX | New | ZOGENIX INC | $3,715,000 | – | 325,000 | +100.0% | 0.60% | – |
| KITE | New | KITE PHARMA INCcall | $3,631,000 | – | 65,000 | +100.0% | 0.59% | – |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $3,340,000 | – | 250,000 | +100.0% | 0.54% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $3,181,000 | – | 20,000 | +100.0% | 0.52% | – |
| CYH | New | COMMUNITY HEALTH SYS INC NEWcall | $2,885,000 | – | 250,000 | +100.0% | 0.47% | – |
| EXAS | New | EXACT SCIENCES CORP | $2,786,000 | – | 150,000 | +100.0% | 0.45% | – |
| AKBA | New | AKEBIA THERAPEUTICS INC | $2,715,000 | – | 300,000 | +100.0% | 0.44% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $2,633,000 | – | 325,000 | +100.0% | 0.43% | – |
| New | NEURODERM LTD | $2,422,000 | – | 131,000 | +100.0% | 0.39% | – | |
| DVAX | New | DYNAVAX TECHNOLOGIES CORPcall | $2,098,000 | – | 200,000 | +100.0% | 0.34% | – |
| OPHT | New | OPHTHOTECH CORPput | $2,011,000 | – | 43,600 | +100.0% | 0.33% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $1,847,000 | – | 111,000 | +100.0% | 0.30% | – |
| TXMD | New | THERAPEUTICSMD INC | $1,703,000 | – | 250,000 | +100.0% | 0.28% | – |
| ITEK | New | INOTEK PHARMACEUTICALS CORP | $1,612,000 | – | 170,000 | +100.0% | 0.26% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $1,463,000 | – | 157,962 | +100.0% | 0.24% | – |
| ARIA | New | ARIAD PHARMACEUTICALS INCput | $1,369,000 | – | 100,000 | +100.0% | 0.22% | – |
| AVXS | New | AVEXIS INC | $1,094,000 | – | 26,536 | +100.0% | 0.18% | – |
| IONS | New | IONIS PHARMACEUTICALS INC | $916,000 | – | 25,000 | +100.0% | 0.15% | – |
| NVAX | New | NOVAVAX INCcall | $832,000 | – | 400,000 | +100.0% | 0.14% | – |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $524,000 | – | 16,000 | +100.0% | 0.08% | – |
| QTNT | New | QUOTIENT LTD | $469,000 | – | 60,000 | +100.0% | 0.08% | – |
| NVAX | New | NOVAVAX INCput | $416,000 | – | 200,000 | +100.0% | 0.07% | – |
| ITEK | New | INOTEK PHARMACEUTICALS CORPcall | $196,000 | – | 20,700 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.